Avalo Therapeutics (AVTX) News Today $8.91 -0.17 (-1.87%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Avalo Therapeutics initiated with a Buy at BTIGDecember 21 at 12:57 AM | markets.businessinsider.comBTIG Initiates Coverage of Avalo Therapeutics (AVTX) with Buy RecommendationDecember 21 at 12:57 AM | msn.comBTIG Research Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX)BTIG Research initiated coverage on Avalo Therapeutics in a research report on Thursday. They set a "buy" rating and a $40.00 price target for the company.December 19 at 9:22 AM | marketbeat.comLUCID CAPITAL MARKETS Initiates Coverage of Avalo Therapeutics (AVTX) with Buy RecommendationDecember 18 at 1:43 AM | msn.comAvalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Large Drop in Short InterestAvalo Therapeutics, Inc. (NASDAQ:AVTX - Get Free Report) was the target of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 5,200 shares, a decrease of 46.9% from the November 15th total of 9,800 shares. Currently, 0.1% of the company's shares are short sold. Based on an average daily volume of 45,100 shares, the short-interest ratio is currently 0.1 days.December 12, 2024 | marketbeat.comRA Capital Management L.P. Invests $9.19 Million in Avalo Therapeutics, Inc. (NASDAQ:AVTX)RA Capital Management L.P. purchased a new position in shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 967,000 shares of the company's stock, valued at approximately $9,186,000. RADecember 5, 2024 | marketbeat.comAvalo Therapeutics receives $69.4M in proceeds from exercise of warrantsNovember 12, 2024 | markets.businessinsider.comAvalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement WarrantsNovember 12, 2024 | globenewswire.comAvalo Therapeutics to Present at Upcoming Investor ConferencesNovember 11, 2024 | globenewswire.comOppenheimer Remains a Buy on Avalo Therapeutics (AVTX)November 9, 2024 | markets.businessinsider.comAvalo Therapeutics (AVTX) Receives a Hold from H.C. WainwrightNovember 9, 2024 | markets.businessinsider.comAvalo Reports Third Quarter 2024 Financial Results and Recent Business UpdatesNovember 7, 2024 | finance.yahoo.comHC Wainwright & Co. Initiates Coverage of Avalo Therapeutics (AVTX) with Neutral RecommendationOctober 24, 2024 | msn.comAvalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis SuppurativaOctober 8, 2024 | globenewswire.comAvalo Therapeutics (NASDAQ:AVTX) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comAvalo Therapeutics (NASDAQ:AVTX) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comAvalo Therapeutics Inc. (C6K0.SG)September 19, 2024 | uk.finance.yahoo.comAvalo Announces Participation in September Investor ConferencesSeptember 4, 2024 | finance.yahoo.comThe 3 Best Personalized Nutrition Stocks to Buy NowJuly 24, 2024 | investorplace.comAvalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical OfficerJuly 16, 2024 | globenewswire.comAvalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis SuppurativaJuly 9, 2024 | globenewswire.comAvalo Therapeutics Announces Appointment of Paul Varki as Chief Legal OfficerJune 24, 2024 | globenewswire.comAvalo to Present at the Oppenheimer Novel Targets in Immunology SummitJune 17, 2024 | globenewswire.comAVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024May 13, 2024 | investorplace.comAvalo Therapeutics: Avalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 13, 2024 | finanznachrichten.deAvalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 13, 2024 | globenewswire.comOppenheimer Upgrades Avalo Therapeutics (AVTX)April 17, 2024 | msn.comAvalo Therapeutics (AVTX) Price Target Increased by 4566.67% to 35.70April 17, 2024 | msn.comWhy VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving PremarketApril 2, 2024 | benzinga.comAvalo Therapeutics Appoints Biotech Leaders to Board of DirectorsApril 2, 2024 | globenewswire.comAvalo Therapeutics Shares More than Triple After Co Acquires AlmataBioMarch 29, 2024 | marketwatch.comAvalo Reports 2023 Financial Results and Provides Business UpdatesMarch 29, 2024 | globenewswire.comAvalo Therapeutics: Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 MillionMarch 29, 2024 | finanznachrichten.deTrading was temporarily halted for "AVTX" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 04:03 PM. March 28, 2024 | marketbeat.comMicro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin DisorderMarch 28, 2024 | msn.comTrading was temporarily halted for "AVTX" at 09:03 AM with a stated reason of "LULD pause."March 28, 2024 | marketbeat.comWhy Is Avalo Therapeutics (AVTX) Stock Up 326% Today?March 28, 2024 | investorplace.comAvalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 MillionMarch 27, 2024 | globenewswire.comAvalo (AVTX) to Report Q4 Earnings: What's in the Cards?February 26, 2024 | finance.yahoo.comAvalo Therapeutics Stock (NASDAQ:AVTX) Dividends: History, Yield and DatesJanuary 2, 2024 | benzinga.comTrading was temporarily halted for "AVTX" at 07:12 PM with a stated reason of "News pending."December 29, 2023 | marketbeat.comAvalo Therapeutics announces a 1-for-240 reverse stock splitDecember 27, 2023 | msn.comAvalo Therapeutics Announces 1-for-240 Reverse Stock SplitDecember 27, 2023 | finance.yahoo.comAvalo Therapeutics, Inc. (AVTX) stock forecast and price targetDecember 18, 2023 | finance.yahoo.comAvalo Therapeutics: Avalo Encourages Stockholders to Vote FOR the Reverse Stock SplitDecember 7, 2023 | finanznachrichten.deAvalo Encourages Stockholders to Vote FOR the Reverse Stock SplitDecember 7, 2023 | finance.yahoo.comAvalo Therapeutics Stock (NASDAQ:AVTX) Earnings Dates and Earning CallsNovember 11, 2023 | benzinga.comAvalo Therapeutics Inc AVTXNovember 9, 2023 | morningstar.comAvalo Therapeutics Inc (AVTX) Announces Q3 2023 Financial Results and Strategic AdvancesNovember 9, 2023 | finance.yahoo.comAvalo Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNovember 9, 2023 | finance.yahoo.com Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 AVTX Media Mentions By Week AVTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVTX News Sentiment▼0.200.60▲Average Medical News Sentiment AVTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVTX Articles This Week▼50▲AVTX Articles Average Week Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cryoport News Today Neurogene News Today Procaps Group News Today biote News Today Design Therapeutics News Today Voyager Therapeutics News Today Contineum Therapeutics News Today Acelyrin News Today Kamada News Today Canopy Growth News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTX Stock Alerts